Metformin is a biguanide with several mechanisms of action, which include the activation of AMPK associated with the inhibition of respiratory chain complex I and the ability to upregulate nNOS, which is defective in DMD. This evidence concerns the gene NOS1 and Duchenne muscular dystrophy.